News • Radiation oncology
Successful testing at the Medstar Southern Maryland Hospital
IBA (Ion Beam Applications S.A.), the world’s leading provider of proton therapy solutions and radiation therapy integrated quality assurance (QA) for the treatment of cancer, announces the successful commissioning of the Varian Halcyon at the Radiation Oncology Center at MedStar Southern Maryland Hospital Center, based on IBA Dosimetry independent beam scanning solution.
IBA has designed myQA HALO, a dedicated solution that allows medical physicists to efficiently and accurately perform all the required scanning for commissioning, acceptance and annual testing of the Halcyon system. The team at MedStar Health has now successfully commissioned their new Halcyon Machine version 2.0 using the myQA HALO solution. The entire commissioning work including system setup and all measurements was completed efficiently in one day as confirmation of the Gold Standard data used in the RTPS.
“We are excited about the fast adoption of IBA Dosimetry’s dedicated solutions for Integrated Quality Assurance for the Varian Halcyon system,” said Jean-Marc Bothy, President of IBA Dosimetry GmbH. “We are proud that the team at MedStar has chosen the myQA HALO for the commissioning and upcoming QA work.”
02.04.2019
